These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 12028458

  • 1. Outcome of relapse in lupus nephritis: roles of reversal of renal fibrosis and response of inflammation to therapy.
    Hill GS, Delahousse M, Nochy D, Thervet E, Vrtovsnik F, Rémy P, Glotz D, Bariéty J.
    Kidney Int; 2002 Jun; 61(6):2176-86. PubMed ID: 12028458
    [Abstract] [Full Text] [Related]

  • 2. Predictive power of the second renal biopsy in lupus nephritis: significance of macrophages.
    Hill GS, Delahousse M, Nochy D, Rémy P, Mignon F, Méry JP, Bariéty J.
    Kidney Int; 2001 Jan; 59(1):304-16. PubMed ID: 11135084
    [Abstract] [Full Text] [Related]

  • 3. A new morphologic index for the evaluation of renal biopsies in lupus nephritis.
    Hill GS, Delahousse M, Nochy D, Tomkiewicz E, Rémy P, Mignon F, Méry JP.
    Kidney Int; 2000 Sep; 58(3):1160-73. PubMed ID: 10972679
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Interstitial inflammation and long-term renal outcomes in lupus nephritis.
    Alsuwaida AO.
    Lupus; 2013 Dec; 22(14):1446-54. PubMed ID: 24097970
    [Abstract] [Full Text] [Related]

  • 7. Collapsing glomerulopathy in 19 patients with systemic lupus erythematosus or lupus-like disease.
    Salvatore SP, Barisoni LM, Herzenberg AM, Chander PN, Nickeleit V, Seshan SV.
    Clin J Am Soc Nephrol; 2012 Jun; 7(6):914-25. PubMed ID: 22461531
    [Abstract] [Full Text] [Related]

  • 8. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
    Conlon PJ, Fischer CA, Levesque MC, Smith SR, St Clair EW, Allen NB, Fleming JA, Howell DN.
    Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
    [Abstract] [Full Text] [Related]

  • 9. Analysis of clinicopathologic correlations in Iranian patients with lupus nephritis.
    Shariati-Sarabi Z, Ranjbar A, Monzavi SM, Esmaily H, Farzadnia M, Zeraati AA.
    Int J Rheum Dis; 2013 Dec; 16(6):731-8. PubMed ID: 24382282
    [Abstract] [Full Text] [Related]

  • 10. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
    Mok CC, Ying KY, Tang S, Leung CY, Lee KW, Ng WL, Wong RW, Lau CS.
    Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
    [Abstract] [Full Text] [Related]

  • 11. An observational study of outcome in SLE patients with biopsy-verified glomerulonephritis between 1986 and 2004 in a defined area of southern Sweden: the clinical utility of the ACR renal response criteria and predictors for renal outcome.
    Nived O, Hallengren CS, Alm P, Jönsen A, Sturfelt G, Bengtsson AA.
    Scand J Rheumatol; 2013 Aug; 42(5):383-9. PubMed ID: 23829689
    [Abstract] [Full Text] [Related]

  • 12. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
    Shen K, Yu Y, Tang Z, Liu Z, Li L.
    Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
    [Abstract] [Full Text] [Related]

  • 13. [Clinical course and prognostic factors in lupus nephropathy].
    Gamba G, Quintanilla L, del Bosque MD, Chew-Wong A, Correa-Rotter R.
    Rev Invest Clin; 2000 Jul; 52(4):397-405. PubMed ID: 11061101
    [Abstract] [Full Text] [Related]

  • 14. Interstitial inflammatory and chronic tubulointerstitial lesions in lupus nephritis: comparison with those in IgA nephropathy.
    Yamamoto T, Nagase M, Hishida A, Honda N.
    Lupus; 1993 Aug; 2(4):261-8. PubMed ID: 8268975
    [Abstract] [Full Text] [Related]

  • 15. Remission of lupus nephritis: the trajectory of histological response in successfully treated patients.
    Malvar A, Alberton V, Lococo B, Lourenco M, Martinez J, Burna L, Besso C, Navarro J, Nagaraja HN, Khatiwada A, Wolf B, Rovin B.
    Lupus Sci Med; 2023 May; 10(1):. PubMed ID: 37258036
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of repeat biopsy in lupus nephritis: Histopathologic worsening and a short time between biopsies is associated with significantly increased risk for end stage renal disease and death.
    Arriens C, Chen S, Karp DR, Saxena R, Sambandam K, Chakravarty E, James JA, Merrill JT.
    Clin Immunol; 2017 Dec; 185():3-9. PubMed ID: 27923701
    [Abstract] [Full Text] [Related]

  • 17. Remission of proteinuria indicates good prognosis in patients with diffuse proliferative lupus nephritis.
    Koo HS, Kim S, Chin HJ.
    Lupus; 2016 Jan; 25(1):3-11. PubMed ID: 26159540
    [Abstract] [Full Text] [Related]

  • 18. Long-term renal outcomes in multi-ethnic Southeast Asians with lupus nephritis: a retrospective cohort study.
    Lim CC, Tan HZ, Hao Y, Chin YM, Woo KT, Chan CM, Choo JCJ.
    Intern Med J; 2018 Sep; 48(9):1117-1123. PubMed ID: 29740923
    [Abstract] [Full Text] [Related]

  • 19. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system.
    Yu F, Wu LH, Tan Y, Li LH, Wang CL, Wang WK, Qu Z, Chen MH, Gao JJ, Li ZY, Zheng X, Ao J, Zhu SN, Wang SX, Zhao MH, Zou WZ, Liu G.
    Kidney Int; 2010 May; 77(9):820-9. PubMed ID: 20182417
    [Abstract] [Full Text] [Related]

  • 20. Severity of systemic lupus erythematosus with diffuse proliferative glomerulonephritis and the ineffectiveness of standard pulse intravenous cyclophosphamide therapy in Jamaican patients.
    Williams W, Bhagwandass A, Sargeant LA, Shah D.
    Lupus; 2003 May; 12(8):640-5. PubMed ID: 12945726
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.